Encontrados 4 documentos, a visualizar página 1 de 1
Hormonal contraceptives and the length of their use are not independent risk fa...
Longatto Filho, Adhemar; Hammes, L. Serpa; Sarian, L.; Roteli-Martins, C.; Derchain, S.; Eržen, M.; Branca, M.; Tatti, S.; Naud, P.; Matos, J. C.AIMS: To evaluate the role of hormonal contraceptives as a risk factor of high-risk human papillomavirus (HR-HPV), cervical intraepithelial lesions (CIN) and cervical cancer in our multi-center population-based LAMS (Latin American Screening) study. METHODS: A cohort study with >12,000 women from Brazil and Argentina using logistic regression to analyze the covariates of hormonal contraception (HOC - oral, inje...
Interlaboratory quality control in gynecologic cytopathology using the novel co...
Alderisio, M.; Branca, M.; Eržen, M.; Longatto Filho, Adhemar; Derchain, S. F.; Tatti, S.; Vighi, S.; Roteli-Martins, C.; Leoncini, L.
Human papillomavirus testing as an optional screening tool in low-resource sett...
Longatto Filho, Adhemar; Eržen, M.; Branca, M.; Roteli-Martins, C.; Naud, P.; Derchain, S. F.; Hammes, L.; Sarian, L. O.; Bragança, J. F.; Matos, J. C.Hybrid capture II (HC II) test for oncogenic human papillomaviruses (HPV) was carried out in a cohort of 4284 women at their first clinical visit. Overall prevalence of HPV was 17.1%, decreasing with age from 33.9% among women below 20 years to only 11.0% among those older than 41 years. HPV prevalence was significantly higher among current smokers (odds ratio [OR] ¼ 1.31; 95% CI 1.1–1.6), in women with two or ...
Evaluation of visual inspection with acetic acid (VIA), Lugol’s iodine (VILI), ...
Sarian, L. O.; Derchain, S. F.; Naud, P.; Roteli-Martins, C.; Longatto Filho, Adhemar; Tatti, S.; Branca, M.; Dôres, Gerson B. das; Costa, S.Objectives: To assess the performance indicators of visual inspection with acetic acid (VIA) and visual inspection with Lugol’s iodine (VILI) in four Latin American centres participating in the ongoing Latin AMerican Screening (LAMS) study, in settings with moderate incidence of cervical disease and with poorly to moderately well-organized cervical cancer screening. Setting: Three Brazilian centres (São Paulo, ...
| Financiadores do RCAAP | |||||||
|
|
|
|
|
|
||